latrepirdine has been researched along with sam-531 in 2 studies
| Studies (latrepirdine) | Trials (latrepirdine) | Recent Studies (post-2010) (latrepirdine) | Studies (sam-531) | Trials (sam-531) | Recent Studies (post-2010) (sam-531) |
|---|---|---|---|---|---|
| 126 | 7 | 59 | 5 | 0 | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benhamú, B; López-Rodríguez, ML; Martín-Fontecha, M; Pardo, L; Vázquez-Villa, H | 1 |
| Baltrukevich, H; Czarnota, K; Handzlik, J; Kucwaj-Brysz, K | 1 |
2 review(s) available for latrepirdine and sam-531
| Article | Year |
|---|---|
Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer's disease.
Topics: Alzheimer Disease; Binding Sites; Clinical Trials as Topic; Cognition Disorders; Humans; Models, Molecular; Molecular Structure; Protein Structure, Tertiary; Receptors, Serotonin; Serotonin Antagonists | 2014 |
Chemical update on the potential for serotonin 5-HT
Topics: Alzheimer Disease; Animals; Humans; Nootropic Agents; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 2021 |